Last reviewed · How we verify

NCT05939206: rTARUP FU

rTARUP: Long-term Analysis

Completed Last updated 11 April 2025
What this trial tests

trial testing rTARUP in Umbilical Hernia in 111 participants. Completed in 20 December 2024.

Timeline
22 April 2023
Primary endpoint
20 December 2024
20 December 2024

Quick facts

Lead sponsorAlgemeen Ziekenhuis Maria Middelares
StatusCompleted
Study typeOBSERVATIONAL
Enrollment111
Start date22 April 2023
Primary completion20 December 2024
Estimated completion20 December 2024
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Algemeen Ziekenhuis Maria Middelares — full company profile →

Who can join

Eligibility, any sex, with Umbilical Hernia or TARUP. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the recurrence rate and potential long-term complications, at least 48 months, after a robotic assisted transabdominal retromuscular approach (rTARUP technique) for the repair of an umbilical hernia.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Lateral single-dock robot-assisted retro-rectus ventral hernia repair (rTARUP/rTARM): observational study on long-term follow-up.
    Vierstraete M, De Troyer A, Pletinckx P, Hermie E, et al · · 2025 · cited 3× · PMID 40014163 · DOI 10.1007/s11701-025-02243-2

Verify or expand the search:

Other recruiting trials for Umbilical Hernia

Currently open trials in the same condition.

Other Algemeen Ziekenhuis Maria Middelares trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05939206.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing